Listar por autor "Zarcos-Pedrinaci, Irene"
Mostrando ítems 1-3 de 3
-
Factors that influence treatment delay in patients with colorectal cancer
Zarcos-Pedrinaci, Irene; Fernández López, Alberto; Téllez-Santana, Teresa
; Rivas-Ruiz, Francisco; Rueda-Domínguez, Antonio; Morales-Suárez-Varela, María Manuela; Briones, Eduardo; Baré, Marisa; Escobar, Antonio; Sarasqueta, Cristina; Fernández-de Larrea-Baz, Nerea; Aguirre, Urko; Quintana, José María; Redondo-Bautista, Maximino[et al.] (IMPACT JOURNALS LLC, 2017)
A prospective study was performed of patients diagnosed with colorectal cancer (CRC), distinguishing between colonic and rectal location, to determine the factors that may provoke a delay in the first treatment (DFT) ... -
Influence of depression on survival of colorectal cancer patients drawn from a large prospective cohort
Varela-Moreno, Esperanza; Rivas-Ruiz, Francisco; Padilla Ruiz, María del Carmen; Alcaide-García, Julia; Zarcos-Pedrinaci, Irene; Téllez-Santana, Teresa; Fernández-de Larrea-Baz, Nerea; Baré, Marisa; Bilbao, Amaia; Sarasqueta, Cristina; Morales-Suárez-Varela, María Manuela; Aguirre, Urko; Quintana, José María; Redondo-Bautista, Maximino[et al.] (Wiley, 2022-08-21)
Objective The prevalence of depressive symptoms immediately after the diagnosis of colorectal cancer (CRC) is high and has important implications both psychologically and on the course of the disease. The aim of this ... -
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy.
Santonja, Ángela; Sánchez-Muñoz, Alfonso; Lluch, Ana; Chica Parrado, María del Rosario; Albanell, J.; Chacón, José Ignacio; Antolín, Silvia; Jerez-Aragonés, José Manuel; De la Haba, Juan; De Luque, Vanessa; Fernández-De-Sousa, Cristina Elisabeth; Vicioso-Recio, Luis Prudencio; Plata-Fernández, Yéssica; Ramírez-Tortosa, César; Álvarez-Pérez, Martína; Llácer, Casilda; Zarcos-Pedrinaci, Irene; Carrasco, Eva; Caballero, Rosalía; Martín, Miguel; Alba-Conejo, Emilio[et al.] (Impact Journals, 2018-05-29)
Triple negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study is to explore the clinical ...